Prospective Registry Of Therapeutic EndoscopiC ulTrasound

NCT ID: NCT04813055

Last Updated: 2024-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

510 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-01

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This registry aims to analyze long-term outcomes of therapeutic EUS (T-EUS) procedures, as well as to describe clinical and technical variables potentially predicting clinical success or adverse events, for a better selection of ideal candidates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational, prospective, single centre study. This registry aims to evaluate long-term clinical success of EUS-guided therapeutic interventions (T-EUS), as well as adverse events, and clinical and technical variables asociated with clinical success and adverse events.

For the purpose of this registry, the following procedures will be considered to be T-EUS procedures:

* EUS-guided collection drainage
* EUS-guided biliary drainage
* EUS-guided gallbladder drainage
* EUS-guided gastro-enterostomy
* EUS-directed ERCP
* EUS-guided pancreatic duct drainage

Each patient will be assigned to a procedure following standard clinical practice, in most instances following a routinely multidisciplinary discussion.

All patients eligible for the abovementioned clinical indications, but finally undergoing alternative procedures (e.g. surgical interventions, percutaneous interventions or other endoscopic procedures) will be proposed to be enrolled in the registry as "controls". The same variables will be collected, with the exception of technical variables related to the EUS-guided intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Outlet Obstruction Biliary Obstruction Acute Pancreatic Fluid Collection Acute Pancreatitis With Infected Necrosis Acute Cholecystitis Chronic Pancreatitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Endoscopic ultrasound Therapeutic EUS Interventional EUS Biliary Drainage Gastro-jejunostomy Gallbladder Drainage Endoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Therapeutic EUS

Procedures involving Linear Echoendoscopes to create a communication between the gastrointestinal tract and a target organ (biliary tree, pancreatic duct, fluid collection, gallbladder, downstream gastrointestinal tract) through plastic or metal stents.

Therapeutic EUS

Intervention Type PROCEDURE

1. EUS-guided collection drainage (transgastric or transduodenal, performed by Lumen Apposing Metal Stents or double pigtail stents) and eventual endoscopic necrosectomy
2. EUS-guided biliary drainage (either of the extrahepatic or intrahepatic biliary tree / transduodenal or transgastric / either as access for subsequent rendez-vous or transpapillary stenting OR for transparietal stenting by metal or plastic stents).
3. EUS-guided gallbladder drainage via Lumen Apposing Metal Stents and eventual subsequent EUS-based cholecystolithotomy
4. EUS-guided gastro-jejunostomy through Lumen Apposing Metal Stents
5. EUS-directed ERCP in post-surgical anatomy (by gastro-gastrostomy or entero-enterostomy performed through Lumen Apposing Metal Stents)
6. EUS-guided pancreatic duct drainage

Controls

Patients eligible for T-EUS procedures, but undergoing alternative surgical interventions, percutaneous interventions (e.g. Percutaneous Biliary Drainage) or non-EUS based endoscopic procedures (e.g. enteral stenting)

Percutaneous Procedures

Intervention Type PROCEDURE

Procedures involving a percutaneous access to a target region (fluid collection, gallbladder, biliary tree)

Surgical Interventions

Intervention Type PROCEDURE

Surgical interventions to obtain a drainage (e.g. surgical necrosectomy, pancreatico-gastrostomy) or the bypass of a stricture (hepatico-jejunostomy or gastro-jejunostomy)

non-EUS-based endoscopic procedures

Intervention Type PROCEDURE

Other endoscopic procedures not involving EUS (enteral stenting, Enteroscopy-assisted ERCP)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapeutic EUS

1. EUS-guided collection drainage (transgastric or transduodenal, performed by Lumen Apposing Metal Stents or double pigtail stents) and eventual endoscopic necrosectomy
2. EUS-guided biliary drainage (either of the extrahepatic or intrahepatic biliary tree / transduodenal or transgastric / either as access for subsequent rendez-vous or transpapillary stenting OR for transparietal stenting by metal or plastic stents).
3. EUS-guided gallbladder drainage via Lumen Apposing Metal Stents and eventual subsequent EUS-based cholecystolithotomy
4. EUS-guided gastro-jejunostomy through Lumen Apposing Metal Stents
5. EUS-directed ERCP in post-surgical anatomy (by gastro-gastrostomy or entero-enterostomy performed through Lumen Apposing Metal Stents)
6. EUS-guided pancreatic duct drainage

Intervention Type PROCEDURE

Percutaneous Procedures

Procedures involving a percutaneous access to a target region (fluid collection, gallbladder, biliary tree)

Intervention Type PROCEDURE

Surgical Interventions

Surgical interventions to obtain a drainage (e.g. surgical necrosectomy, pancreatico-gastrostomy) or the bypass of a stricture (hepatico-jejunostomy or gastro-jejunostomy)

Intervention Type PROCEDURE

non-EUS-based endoscopic procedures

Other endoscopic procedures not involving EUS (enteral stenting, Enteroscopy-assisted ERCP)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* subjects candidate to therapeutic EUS (T-EUS) procedures for any underlying disease
* 18 years old or older
* able to provide an informed consent to inclusion.

Exclusion Criteria

* age \< 18 years
* inability or unwillingness to sign the informed consent form (ICF)
* contra-indication for endoscopy or use of fluoroscopy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Paolo Giorgio Arcidiacono, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paolo Giorgio Arcidiacono, MD

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paolo Giorgio Arcidiacono, MD, FASGE

Role: PRINCIPAL_INVESTIGATOR

IRCCS San Raffaele Scientific Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS San Raffaele Scientific Institute

Milan, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Giuseppe Vanella, MD

Role: CONTACT

Phone: +390226439574

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Giuseppe Vanella, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

DeWitt JM, Arain M, Chang KJ, Sharaiha R, Komanduri S, Muthusamy VR, Hwang JH; AGA Center for GI Innovation and Technology. Interventional Endoscopic Ultrasound: Current Status and Future Directions. Clin Gastroenterol Hepatol. 2021 Jan;19(1):24-40. doi: 10.1016/j.cgh.2020.09.029. Epub 2020 Sep 18.

Reference Type BACKGROUND
PMID: 32950747 (View on PubMed)

Teoh AYB, Dhir V, Kida M, Yasuda I, Jin ZD, Seo DW, Almadi M, Ang TL, Hara K, Hilmi I, Itoi T, Lakhtakia S, Matsuda K, Pausawasdi N, Puri R, Tang RS, Wang HP, Yang AM, Hawes R, Varadarajulu S, Yasuda K, Ho LKY. Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel. Gut. 2018 Jul;67(7):1209-1228. doi: 10.1136/gutjnl-2017-314341. Epub 2018 Feb 20.

Reference Type BACKGROUND
PMID: 29463614 (View on PubMed)

Vanella G, Leone R, Frigo F, Bronswijk M, van Wanrooij RLJ, Tamburrino D, Orsi G, Belfiori G, Macchini M, Reni M, Aldrighetti L, Falconi M, Capurso G, van der Merwe S, Arcidiacono PG. Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study. DEN Open. 2024 Oct 6;5(1):e70024. doi: 10.1002/deo2.70024. eCollection 2025 Apr.

Reference Type DERIVED
PMID: 39377069 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

178/INT/2020

Identifier Type: -

Identifier Source: org_study_id